These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37857461)

  • 41. Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the Consolidated Framework for Implementation Research.
    Garbutt JM; Dodd S; Walling E; Lee AA; Kulka K; Lobb R
    BMC Fam Pract; 2018 May; 19(1):53. PubMed ID: 29734944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
    Biederman E; Champion V; Zimet G
    BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Barriers to and facilitators of implementing colorectal cancer screening evidence-based interventions in federally qualified health centers: a qualitative study.
    Dias EM; Padilla JR; Cuccaro PM; Walker TJ; Balasubramanian BA; Savas LS; Valerio-Shewmaker MA; Chenier RS; Fernandez ME
    BMC Health Serv Res; 2024 Jul; 24(1):797. PubMed ID: 38987761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
    Megersa BS; Bussmann H; Bärnighausen T; Muche AA; Alemu K; Deckert A
    PLoS One; 2020; 15(12):e0243036. PubMed ID: 33306681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "Black Women Don't Always Put Our Healthcare First": Facilitators and Barriers to Cervical Cancer Screening and Perceptions of Human Papillomavirus Self-Testing Among Church-Affiliated African American Women.
    Christensen K; Bauer AG; Burgin T; Williams J; McDowd J; Sutkin G; Bennett K; Bowe Thompson C; Berkley-Patton JY
    Community Health Equity Res Policy; 2024 Jan; 44(2):137-150. PubMed ID: 36125430
    [No Abstract]   [Full Text] [Related]  

  • 46. Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
    Kositamongkol C; Kanchanasurakit S; Mepramoon E; Talungchit P; Chaopotong P; Kengkla K; Chaisathaphol T; Saokaew S; Phisalprapa P
    BMC Public Health; 2023 Dec; 23(1):2413. PubMed ID: 38049773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
    Devotta K; Vahabi M; Prakash V; Lofters A
    BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention.
    Morse RM; Brown J; Ríos López EJ; Prieto BA; Kohler-Smith A; Gonzales Díaz K; Figueredo Escudero M; Lenin Del Cuadro D; Vásquez Del Aguila G; Daza Grandez H; Meza-Sánchez G; Tracy JK; Gravitt PE; Paz-Soldan VA;
    BMC Public Health; 2024 Aug; 24(1):2121. PubMed ID: 39107728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of WHO guidelines for cervical cancer screening, diagnosis and treatment: knowledge and perceptions of health providers from Argentina.
    Arrossi S; Straw C; Sanchez Antelo V; Paolino M; Baena A; Forestier M; Rol M; Almonte M
    BMC Cancer; 2024 Aug; 24(1):996. PubMed ID: 39134975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study.
    Adewumi K; Nishimura H; Oketch SY; Adsul P; Huchko M
    J Cancer Educ; 2022 Aug; 37(4):1122-1128. PubMed ID: 33411253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Women's acceptability of a self-collect HPV same-day screen-and-treat program in a high burden setting in the Pacific.
    Camara H; Nosi S; Munnull G; Badman SG; Bolgna J; Kuk J; Mola G; Guy R; Vallely AJ; Kelly-Hanku A
    BMC Health Serv Res; 2022 Dec; 22(1):1514. PubMed ID: 36510192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dominican Provider Attitudes Towards HPV Testing for Cervical Cancer Screening and, Current Challenges to Cervical Cancer Prevention in the Dominican Republic: a Mixed Methods Study.
    Liebermann E; Van Devanter N; Frías Gúzman N; Hammer MJ; Ompad D
    J Cancer Educ; 2021 Dec; 36(6):1170-1185. PubMed ID: 32307667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
    Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
    BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A reproductive justice approach to understanding women's experiences with HPV and cervical cancer prevention.
    Sundstrom B; Smith E; Delay C; Luque JS; Davila C; Feder B; Paddock V; Poudrier J; Pierce JY; Brandt HM
    Soc Sci Med; 2019 Jul; 232():289-297. PubMed ID: 31121439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of the Carolina Framework for Cervical Cancer Prevention.
    Moss JL; McCarthy SH; Gilkey MB; Brewer NT
    Gynecol Oncol; 2014 Mar; 132 Suppl 1(0 1):S33-40. PubMed ID: 24333357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country.
    Arrossi S; Ramos S; Straw C; Thouyaret L; Orellana L
    BMC Public Health; 2016 Aug; 16():832. PubMed ID: 27538390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.
    Tiro JA; Betts AC; Kimbel K; Buist DSM; Mao C; Gao H; Shulman L; Malone C; Beatty T; Lin J; Thayer C; Miglioretti DL; Winer RL
    J Womens Health (Larchmt); 2019 Mar; 28(3):384-392. PubMed ID: 30481121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.